{
    "Trade/Device Name(s)": [
        "Etest Ceftazidime/Avibactam (CZA)",
        "Etest CZA"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K172150",
    "Predicate Device Reference 510(k) Number(s)": [
        "K170670"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY"
    ],
    "Summary Letter Date": "September 15, 2017",
    "Summary Letter Received Date": "July 17, 2017",
    "Submission Date": "July 13, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Ceftazidime/Avibactam"
    ],
    "Specimen Type(s)": [
        "Bacterial isolate (aerobic Gram-negative and Gram-positive, and fastidious bacteria)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Antibiotic gradient diffusion",
        "Agar-based MIC determination"
    ],
    "Methodologies": [
        "Quantitative antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for Etest Ceftazidime/Avibactam (CZA) strip for quantitative agar-based MIC antimicrobial susceptibility testing of Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Quantitative technique to determine antimicrobial susceptibility (MIC) of both non-fastidious Gram-negative and Gram-positive aerobic and fastidious bacteria to Ceftazidime/Avibactam, used on agar media with overnight incubation.",
    "fda_folder": "Microbiology"
}